WHO ICTRP trial
Evaluation of the effectiveness and safety of ALKACITRAT® on the treatment of…
CTIS2024-512688-30-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-512688-30-00 |
|---|---|
| Public title | Evaluation of the effectiveness and safety of ALKACITRAT® on the treatment of functional dyspepsia |
| Scientific title | Evaluation of the effectiveness and safety of ALKACITRAT® on the treatment of functional dyspepsia - UNI-BETAIN |
| Primary sponsor | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): Yes |
| Countries | Greece |
| Conditions | Functional Dyspepsia MedDRA version: 20.1Level: LLTClassification code: 10064536Term: Functional dyspepsia Class: 10017947;Therapeutic area: Diseases [C] - Digestive System Diseases [C06];MedDRA version: 20.1Level: LLTClassification code… |
| Interventions | Product Name: The placebo has the same composition as the investigational medicinal product alkacitrat effervescent tablet 2 g/tab (with the exception of the active substance), is manufactured by the same manufacturer (uni-pharma kleon… |
| Registration date | Mar 22, 2024 |
| Target size | 92 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: